Balakrishnar B - Search Results

1

Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio.

Lee CI, Low SK, Maldonado R, Fox P, Balakrishnar B, Coulter S, de Bruijn P, Koolen SLW, Gao B, Lynch J, Zdenkowski N, Hui R, Liddle C, Mathijssen RHJ, Wilcken N, Wong M, Gurney H. Lee CI, et al. Among authors: balakrishnar b. Breast. 2020 Dec;54:229-234. doi: 10.1016/j.breast.2020.10.008. Epub 2020 Oct 21. Breast. 2020. PMID: 33161337 Free PMC article.

2

Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study.

Fox P, Balleine RL, Lee C, Gao B, Balakrishnar B, Menzies AM, Yeap SH, Ali SS, Gebski V, Provan P, Coulter S, Liddle C, Hui R, Kefford R, Lynch J, Wong M, Wilcken N, Gurney H. Fox P, et al. Among authors: balakrishnar b. Clin Cancer Res. 2016 Jul 1;22(13):3164-71. doi: 10.1158/1078-0432.CCR-15-1470. Epub 2016 Feb 4. Clin Cancer Res. 2016. PMID: 26847054 Clinical Trial.

3

Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?

Lee CI, Fox P, Balakrishnar B, Balleine RL, Gao B, Provan P, Coulter S, Liddle C, Hui R, Wong M, Gurney H, Wilcken N. Lee CI, et al. Among authors: balakrishnar b. Breast. 2019 Aug;46:52-57. doi: 10.1016/j.breast.2019.05.009. Epub 2019 May 6. Breast. 2019. PMID: 31082762

4

Evidence for therapeutic drug monitoring of targeted anticancer therapies.

Gao B, Yeap S, Clements A, Balakrishnar B, Wong M, Gurney H. Gao B, et al. Among authors: balakrishnar b. J Clin Oncol. 2012 Nov 10;30(32):4017-25. doi: 10.1200/JCO.2012.43.5362. Epub 2012 Aug 27. J Clin Oncol. 2012. PMID: 22927532 Review.

5

Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring.

Sabanathan D, Zhang A, Fox P, Coulter S, Gebski V, Balakrishnar B, Chan M, Liddle C, Gurney H. Sabanathan D, et al. Among authors: balakrishnar b. Cancer Chemother Pharmacol. 2017 Aug;80(2):385-393. doi: 10.1007/s00280-017-3362-1. Epub 2017 Jun 30. Cancer Chemother Pharmacol. 2017. PMID: 28667354

6

Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun study.

Kloth JS, Klümpen HJ, Yu H, Eechoute K, Samer CF, Kam BL, Huitema AD, Daali Y, Zwinderman AH, Balakrishnar B, Bennink RJ, Wong M, Schellens JH, Mathijssen RH, Gurney H. Kloth JS, et al. Among authors: balakrishnar b. Clin Pharmacokinet. 2014 Mar;53(3):261-269. doi: 10.1007/s40262-013-0111-4. Clin Pharmacokinet. 2014. PMID: 24234588

7

Patterns of care and outcomes of men with germ cell tumors in a high-volume Australian center.

Arasaratnam M, Balakrishnar B, Crumbaker M, Turner S, Hayden AJ, Brooks A, Patel MI, Lau H, Woo H, Bariol S, Gurney H. Arasaratnam M, et al. Among authors: balakrishnar b. Asia Pac J Clin Oncol. 2022 Apr;18(2):e23-e31. doi: 10.1111/ajco.13548. Epub 2021 Jun 21. Asia Pac J Clin Oncol. 2022. PMID: 34152083

8

Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011.

van Leeuwen MT, Gurney H, Turner JJ, Turner SL, Pearson SA, Laaksonen MA, Harnett P, Balakrishnar B, Sabanathan D, Vajdic CM. van Leeuwen MT, et al. Among authors: balakrishnar b. Cancer Epidemiol. 2016 Aug;43:15-21. doi: 10.1016/j.canep.2016.05.006. Epub 2016 May 26. Cancer Epidemiol. 2016. PMID: 27235952

9

Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability.

Jeffreys SA, Powter B, Balakrishnar B, Mok K, Soon P, Franken A, Neubauer H, de Souza P, Becker TM. Jeffreys SA, et al. Among authors: balakrishnar b. Cells. 2020 Sep 11;9(9):2077. doi: 10.3390/cells9092077. Cells. 2020. PMID: 32932819 Free PMC article. Review.

10

Patterns of Presentation and Treatment Outcomes of Non-clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, Australia.

Naher S, Padinharakam S, Balakrishnar B, Chua W, Descallar J, Adams D, de Souza P, Harrison M, Lim S. Naher S, et al. Among authors: balakrishnar b. Clin Genitourin Cancer. 2019 Jun;17(3):e565-e569. doi: 10.1016/j.clgc.2019.02.006. Epub 2019 Feb 27. Clin Genitourin Cancer. 2019. PMID: 30935815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page